BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36212959)

  • 1. Inchinkoto, the Traditional Japanese Kampo Medicine, Enhances Intestinal Epithelial Barrier Function In Vitro.
    Nakao A; Hu A; Yamaguchi T; Tabuchi M; Ikarashi Y; Kobayashi H
    Evid Based Complement Alternat Med; 2022; 2022():4139812. PubMed ID: 36212959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current scenario for the hepatoprotective effects of Inchinkoto, a traditional herbal medicine, and its clinical application in liver surgery: A review.
    Yokoyama Y; Nagino M
    Hepatol Res; 2014 Apr; 44(4):384-94. PubMed ID: 24450947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Inchinkoto efficacy, in patients with obstructive jaundice associated with malignant tumors, through pharmacomicrobiomics.
    Yamashita H; Nishiyama M; Ohbuchi K; Kanno H; Tsuchiya K; Yamaguchi J; Mizuno T; Ebata T; Nagino M; Yokoyama Y
    Pharmacol Res; 2022 Jan; 175():105981. PubMed ID: 34798264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beneficial effects of preoperative administration of Inchinkoto in patients undergoing major hepatectomy].
    Yokoyama Y; Kokuryo T; Kawai K; Mizutani T; Watanabe S; Nagino M
    Nihon Geka Gakkai Zasshi; 2013 Sep; 114(5):256-60. PubMed ID: 24167979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the intestinal microenvironment have an impact on the choleretic effect of inchinkoto, a hepatoprotective herbal medicine?
    Uji M; Yokoyama Y; Asahara T; Ebata T; Igami T; Mizuno T; Yamaguchi J; Nagino M
    Hepatol Res; 2018 Feb; 48(3):E303-E310. PubMed ID: 28960692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active ingredients of traditional Japanese (kampo) medicine, inchinkoto, in murine concanavalin A-induced hepatitis.
    Mase A; Makino B; Tsuchiya N; Yamamoto M; Kase Y; Takeda S; Hasegawa T
    J Ethnopharmacol; 2010 Feb; 127(3):742-9. PubMed ID: 19962433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.
    Iraha A; Chinen H; Hokama A; Yonashiro T; Kinjo T; Kishimoto K; Nakamoto M; Hirata T; Kinjo N; Higa F; Tateyama M; Kinjo F; Fujita J
    World J Gastroenterol; 2013 Sep; 19(33):5500-7. PubMed ID: 24023493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice.
    Yamamoto M; Miura N; Ohtake N; Amagaya S; Ishige A; Sasaki H; Komatsu Y; Fukuda K; Ito T; Terasawa K
    Gastroenterology; 2000 Feb; 118(2):380-9. PubMed ID: 10648466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers.
    Okada K; Shoda J; Kano M; Suzuki S; Ohtake N; Yamamoto M; Takahashi H; Utsunomiya H; Oda K; Sato K; Watanabe A; Ishii T; Itoh K; Yamamoto M; Yokoi T; Yoshizato K; Sugiyama Y; Suzuki H
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1450-63. PubMed ID: 17038627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A inhibits the action of LPS on the intestinal epithelial barrier function and tight junction proteins.
    He C; Deng J; Hu X; Zhou S; Wu J; Xiao D; Darko KO; Huang Y; Tao T; Peng M; Wang Z; Yang X
    Food Funct; 2019 Feb; 10(2):1235-1242. PubMed ID: 30747184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression.
    Wang Y; Mumm JB; Herbst R; Kolbeck R; Wang Y
    J Immunol; 2017 Nov; 199(9):3316-3325. PubMed ID: 28939759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betaine attenuates LPS-induced downregulation of Occludin and Claudin-1 and restores intestinal barrier function.
    Wu J; He C; Bu J; Luo Y; Yang S; Ye C; Yu S; He B; Yin Y; Yang X
    BMC Vet Res; 2020 Mar; 16(1):75. PubMed ID: 32131830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
    Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
    BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
    Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive metabolome analysis for the pharmacological action of inchinkoto, a hepatoprotective herbal medicine.
    Yamashita H; Ohbuchi K; Nagino M; Ebata T; Tsuchiya K; Kushida H; Yokoyama Y
    Metabolomics; 2021 Dec; 17(12):106. PubMed ID: 34855010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine Blocks Interleukin-13-Induced Intestinal Epithelial Barrier Dysfunction.
    Li M; Oshima T; Ito C; Yamada M; Tomita T; Fukui H; Miwa H
    Digestion; 2021; 102(2):170-179. PubMed ID: 31533100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numb modulates the paracellular permeability of intestinal epithelial cells through regulating apical junctional complex assembly and myosin light chain phosphorylation.
    Yang Y; Chen L; Tian Y; Ye J; Liu Y; Song L; Pan Q; He Y; Chen W; Peng Z; Wang R
    Exp Cell Res; 2013 Dec; 319(20):3214-25. PubMed ID: 23872314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions.
    Putt KK; Pei R; White HM; Bolling BW
    Food Funct; 2017 Jan; 8(1):406-414. PubMed ID: 28091645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.